Structures by: Cho N. S.
Total: 12
C3H5N3O4S
C3H5N3O4S
Journal of the Chemical Society, Perkin Transactions 2 (1999) 1 81
a=5.4492(19)Å b=7.9050(12)Å c=8.7156(15)Å
α=108.173(17)° β=99.135(19)° γ=104.05(3)°
C16H16N4O3S4
C16H16N4O3S4
Acta Crystallographica Section E (2001) 57, 4 o368-o369
a=16.827(2)Å b=14.1071(16)Å c=16.760(4)Å
α=90.00° β=93.950(16)° γ=90.00°
C12H16N4O4S4
C12H16N4O4S4
Acta Crystallographica Section E (2001) 57, 5 o434-o435
a=8.7369(8)Å b=15.741(3)Å c=13.3967(12)Å
α=90.00° β=103.833(8)° γ=90.00°
C14H16N4O8S4
C14H16N4O8S4
Acta Crystallographica Section C (2000) 56, 2 229-230
a=15.151(3)Å b=12.739(3)Å c=10.5509(13)Å
α=90.00° β=97.888(13)° γ=90.00°
Ethyl <i>N</i>-[(benzyloxy)thiocarbonyl]carbamate
C11H13NO3S
Acta Crystallographica Section E (2012) 68, 2 o300
a=6.608(4)Å b=7.963(7)Å c=12.369(6)Å
α=87.451(13)° β=80.725(17)° γ=77.324(18)°
5,5'-[1,4-Phenylenebis(methylenesulfanediyl)]bis[1,3,4-thiadiazol- 2(3<i>H</i>)-one] dimethyl sulfoxide disolvate
C12H10N4O2S4,2(C2H6OS)
Acta Crystallographica Section E (2012) 68, 3 o781
a=7.5723(15)Å b=8.3258(17)Å c=10.346(2)Å
α=109.70(4)° β=95.74(3)° γ=91.15(3)°
<i>N</i>-(5-Sulfanylidene-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide dimethyl sulfoxide disolvate
C4H5N3OS2,2(C2H6OS)
Acta Crystallographica Section E (2012) 68, 1 o224
a=7.090(2)Å b=9.982(3)Å c=11.513(3)Å
α=100.872(6)° β=96.827(4)° γ=91.359(4)°
N-(carbamoylcarbamothioyl)benzamide
C9H9N3O2S
Acta Crystallographica Section E (2012) 68, 2 o395
a=10.4583(3)Å b=12.8103(4)Å c=16.1830(5)Å
α=90° β=106.6930(10)° γ=90°
5-Ethoxy-1,3,4-thiadiazole-2(3<i>H</i>)-thione
C4H6N2OS2
Acta Crystallographica Section E (2012) 68, 2 o503
a=6.0308(12)Å b=8.1171(16)Å c=8.7616(18)Å
α=116.55(4)° β=93.70(3)° γ=106.10(3)°
<i>N</i>-(5-Ethoxy-1,3,4-thiadiazol-2-yl)benzamide
C11H11N3O2S
Acta Crystallographica Section E (2012) 68, 2 o544
a=3.9797(5)Å b=20.138(3)Å c=14.4305(18)Å
α=90° β=92.036(2)° γ=90°
5-Amino-1,3,4-thiadiazol-2(3<i>H</i>)-one
C2H3N3OS
Acta Crystallographica Section E (2012) 68, 4 o1198
a=7.2860(2)Å b=10.2982(3)Å c=10.7727(3)Å
α=63.721(3)° β=73.122(2)° γ=76.737(2)°
5-({3-[(5-Amino-1,3,4-thiadiazol-2-yl)sulfanylmethyl]benzyl}sulfanyl)-1,3,4- thiadiazol-2-amine
C12H12N6S4
Acta Crystallographica Section E (2012) 68, 4 o1241
a=16.3579(10)Å b=6.1382(4)Å c=30.7095(18)Å
α=90° β=90.3730(10)° γ=90°